Genetic Engineering — Methods, CRISPR, Applications & Ethics 🧬
Complete UPSC Notes — Recombinant DNA technology, CRISPR-Cas9, gene silencing, protoplast fusion. Applications in medicine, agriculture, industry. Ethical concerns: designer babies, gene drives, ecological risks. Updated with 2025–26 CRISPR breakthroughs including Casgevy, epigenetic editing, and personalised gene therapy.
🔥 10-Second Revision
🎯 Objectives of Genetic Engineering
🧪 Creating New Genes
Synthesising novel gene sequences and introducing them into target organisms. Uses Recombinant DNA technology.
🔇 Silencing Genes
Selectively turning off genes without altering DNA itself — abolishing their action. Uses RNA interference (RNAi) — gene knockdown.
✂️ Removing Genes
Completely removing a gene's expression (gene knockout). Used for studying diseases and metabolic pathways. Uses rDNA tech + CRISPR.
✏️ Editing Gene Function
Precise modification of a particular gene to control biochemical processes. Used for gene therapy. CRISPR-Cas9 is the tool of choice.
⚙️ Methods of Genetic Engineering
1. Recombinant DNA Technology (rDNA)
Taking a gene from one organism, inserting it into a vector (virus or plasmid), and adding it to the DNA of a target organism. Allows transfer of desired genes between different species.
Steps in rDNA Production:
2. CRISPR-Cas9 Gene Editing
A revolutionary tool that uses a guide RNA to direct the Cas9 enzyme ("molecular scissors") to a precise location in the DNA, where it cuts. The cell's repair machinery then fixes the break — allowing scientists to add, remove, or modify genes with unprecedented accuracy.
Origin: Based on a natural bacterial defence system against viruses. CRISPR sequences in bacterial DNA store virus DNA fragments; Cas9 uses these as guides to find and cut matching viral DNA.
3. Gene Silencing / Gene Knockdown (RNAi)
Turning off specific genes using RNA interference — short complementary RNA molecules (siRNA, miRNA, antisense RNA) bind to mRNA and prevent protein production. Does NOT edit the actual DNA code — effect is temporary/reversible.
4. Protoplast Fusion
Fusing cell-wall-free plant cells (protoplasts) using chemical or electrical means. Creates hybrid cell lines with mixed genomes, then regenerated into whole plants. Introduces disease/stress resistance and improves quality.
💊 Applications of Genetic Engineering
A. Medical / Therapeutic Applications
🎗️ Cancer Therapeutics
CRISPR-modified T-cells (CAR-T therapy) locate and kill cancer cells. Immunotherapy revolution.
💊 Drug Discovery
CRISPR speeds up drug discovery by identifying gene targets. Companies incorporating gene editing in R&D phase.
🧬 Gene Therapy
Single-gene disorders: cystic fibrosis, muscular dystrophy, haemophilia, sickle cell anaemia, AIDS — treated by replacing/repairing defective genes.
💉 Hormones & Vaccines
Bacteria engineered to produce human insulin, growth hormone, alpha interferon, Hepatitis B vaccine via rDNA technology.
❤️ Cardiovascular
CRISPR therapies targeting cholesterol genes (ANGPTL3, PCSK9) — single injection may replace lifelong statins. Clinical trials underway.
👶 Personalised Medicine
First personalised CRISPR therapy created for an individual patient (infant, 2025) — developed in just 6 months. Landmark case.
B. Agricultural Applications
C. Industrial Applications
Protein synthesis in bioreactors using transformed microorganisms. Recombinant enzymes — chymosin and lipase for cheese production, alpha-amylase for beer flavour. Biofuels — engineered microbes to produce ethanol and biodiesel more efficiently.
⚠️ Ethical Concerns & Disadvantages
👶 Designer Babies
Risk of engineering embryos for enhancement (intelligence, appearance) rather than therapy. Germline edits affect all future generations without their consent.
🧬 Off-Target Effects
CRISPR may cut at unintended locations in the genome → permanent mutations, mosaicism. Especially dangerous in germline editing.
🌿 Gene Flow
Engineered genes can transfer to wild species via cross-pollination or horizontal gene transfer. If herbicide-resistance genes spread to weeds → "superweeds."
🦟 Gene Drives
Can spread engineered genes rapidly through wild populations. Eliminating a keystone species could cause cascading ecosystem collapse and permanent biodiversity loss.
🌾 Loss of Genetic Diversity
Uniform GM crop varieties can reduce diversity in wild ancestral varieties via uncontrolled hybridisation. In India, GM cotton hybrids left wild cotton varieties vulnerable.
🔒 Ownership & Access
Patents on genes, cell lines, GM organisms. $2.2 million for Casgevy raises access/equity concerns. Need to balance innovation with affordability.
🆕 CRISPR Breakthroughs (2023–2026)
Dec 2023Casgevy — First CRISPR Medicine Approved 🏆
First-ever approved CRISPR-based medicine. Treats sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Edits the BCL11A gene to reactivate fetal haemoglobin. Approved in US, UK, EU, Canada, Saudi Arabia, UAE. Priced at $2.2 million. By end of 2025, 64 patients received the treatment. 90% of US patients now have reimbursement access.
2025First Personalised CRISPR Therapy 🆕
A bespoke in vivo CRISPR therapy was created for an individual infant patient with a rare genetic disease — developed and delivered in just 6 months. This landmark case sets a precedent for on-demand gene-editing therapies for rare, previously untreatable diseases.
2025CRISPR for Heart Disease
CTX310 — a single IV injection targeting the ANGPTL3 gene — showed deep, durable reductions in both triglycerides and LDL cholesterol. Could potentially replace daily statins with a one-time treatment. Phase 1b trials advancing.
Jan 2026Epigenetic Editing — No DNA Cutting 🆕
UNSW scientists showed CRISPR can turn genes on by removing chemical methyl tags — without cutting DNA at all. Potentially safer than traditional CRISPR. Could treat sickle cell disease by reactivating the fetal globin gene. Published in Nature Communications.
2025250+ CRISPR Clinical Trials Worldwide
As of 2025, over 250 clinical trials involving CRISPR are active globally, spanning blood disorders, cancer (CAR-T), cardiovascular disease, rare diseases, autoimmune conditions, and even infections.
2025PERT — Prime Editing ReadThrough
New technique allows cells to skip over "stop" mutations and finish building proteins. Could theoretically treat thousands of different genetic diseases caused by "nonsense mutations" using a similar mechanism.
📊 Comparison — Gene Editing Methods
| Feature | Recombinant DNA | CRISPR-Cas9 | Gene Silencing (RNAi) | Epigenetic Editing |
|---|---|---|---|---|
| Mechanism | Transfer gene via vector | Cut DNA at target site | Block mRNA → no protein | Add/remove chemical tags on DNA |
| DNA Changed? | Yes (new gene inserted) | Yes (cut + repair) | No — RNA level only | No — tags only |
| Permanent? | Yes | Yes | Temporary / reversible | Potentially reversible |
| Precision | Moderate | Very high | Moderate | High |
| Off-target risk | Low (insertion-based) | Moderate (cutting risk) | Low | Very low |
| Key use | GM crops, insulin | Gene therapy, disease cure | Research, virus resistance | Sickle cell, cancer (emerging) |
| Nobel Prize | 1978 (Berg et al.) | 2020 (Doudna & Charpentier) | 2006 (Fire & Mello) | — |
📝 UPSC-Style MCQs
1. It was originally discovered as a bacterial defence mechanism against viruses.
2. It uses a guide RNA to direct the Cas9 enzyme to a specific DNA location.
3. It can only delete genes, not insert or modify them.
Which of the statements is/are correct?
🧠 Memory Aid — Quick Recall
🔑 Lock These In for Prelims Day
❓ FAQs
What is the difference between gene editing and gene silencing?
What is the "designer baby" controversy?
What is the regulatory framework for GM crops in India?
What is the Nagoya Protocol and how does it relate to genetic engineering?
📜 UPSC Mains — Probable Questions
"What is CRISPR-Cas9? Discuss its applications in medicine and agriculture, and the ethical concerns associated with gene editing technology."
"Discuss the ecological risks of genetically modified organisms (GMOs), with special reference to gene flow and gene drives. What precautionary measures are needed?"
"Examine the potential of gene therapy in treating genetic disorders. What are the ethical dilemmas associated with germline interventions?"
"What is the regulatory framework for GM crops in India? Critically analyse the debate around Bt-brinjal and GM mustard."
🏁 Conclusion
🧬 Rewriting the Code of Life
Genetic engineering stands at an extraordinary inflection point. In December 2023, the first CRISPR-based medicine was approved — a cure, not a treatment, for sickle cell disease. In 2025, a personalised CRISPR therapy was created from scratch for a single infant in just six months. Scientists are now turning genes on and off without ever cutting the DNA strand. Over 250 clinical trials are targeting everything from cancer to heart disease to blindness. The tools are becoming faster, cheaper, more precise, and more powerful with each passing year.
But with this power comes profound responsibility. Gene drives that could erase entire species from ecosystems. Germline edits that would be inherited by generations who never consented. A $2.2 million price tag that raises painful questions about who gets to be cured and who does not. The 2018 case of He Jiankui's gene-edited babies serves as a permanent warning about what happens when science outpaces ethics.
For UPSC aspirants, the key is to understand both the promise and the peril — and to be able to discuss the regulatory, ethical, and ecological dimensions alongside the scientific mechanisms. India's position is complex: it embraces Bt-cotton but holds a moratorium on Bt-brinjal; it has a Biological Diversity Act but faces pressure to adopt more GM technology. The answers lie not in choosing one side but in building frameworks that allow innovation while protecting consent, diversity, and equity.
